Work

EPH141 Effectiveness of Early Remdesivir Initiation in Patients with Immunocompromising Conditions Hospitalized with COVID-19 by Variant Era, Level of Immunocompromise, and Age

Year: 2025

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2025.04.671

Authors: Mark Berry, EunYoung Lee, Valentina Shvachko, Carrie Nielson, Kathleen Wirth Hurwitz, Nuvan Rathnayaka, Rachel W. Faller, Mazin Abdelghany, M. Alan Brookhart, Anand P. Chokkalingam

Institutions: Gilead Sciences (United States), Target PharmaSolutions, Inc. (United States)

Language: English

Topic: COVID-19 Clinical Research Studies

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4412443468

Cites:

Cited by:

Related to: 10